Angie Davidson

14 July 2018

Egypt

Levels of Specific Antibodies Linked to Clinical Characteristics of Lupus, Study Reports

Angie Davidson

14 July 2018

Egypt

Levels of Specific Antibodies Linked to Clinical Characteristics of Lupus, Study Reports

Levels of certain antibodies are significantly associated with particular clinical characteristics of systemic lupus erythematosus (SLE), and could be used to assess disease activity in patients, a study finds.

The study, “Antibodies to extractable nuclear antigens (ENAS) in systemic lupus erythematosus patients: correlations with clinical manifestations and disease activity,” was published in the journal Reumatismo.

Angie Davidson

4 July 2018

France

French Lupus Vaccine Ready to Move Into Phase III

Angie Davidson

4 July 2018

France

French Lupus Vaccine Ready to Move Into Phase III

Neovacs, a French biotech, obtained positive Phase IIb results showing its lupus vaccine could be effective in treating this severe autoimmune disease.

Its lupus vaccine works by stimulating the patient’s immune system to produce antibodies against a protein called IFNα that regulates the immune system and is involved in the disease.

Angie Davidson

29 June 2018

Germany

Many Lupus Patients Reject Vaccinations, German Research Shows

Angie Davidson

29 June 2018

Germany

Many Lupus Patients Reject Vaccinations, German Research Shows

More than one-third of German patients with systemic lupus erythematosus (SLE) did not get vaccinated, largely due to fear of developing a lupus flare or negative side effects related to the vaccines, a new study shows.

Angie Davidson

24 June 2018

USA

Poor Sleep and Depression, via Pain, Can Affect Cognition in Lupus Patients, Study Finds

Angie Davidson

24 June 2018

USA

Poor Sleep and Depression, via Pain, Can Affect Cognition in Lupus Patients, Study Finds

Pain disturbs sleep and can augment depression, two factors that directly impact cognition in people with systemic lupus erythematosus, according to a study that looked into how pain relates to cognitive health in SLE patients.

Angie Davidson

18 June 2018

Japan

Bisphosphonates, Plus Vitamin D, May Help Prevent Heart Disease in SLE Patients

Angie Davidson

18 June 2018

Japan

Bisphosphonates, Plus Vitamin D, May Help Prevent Heart Disease in SLE Patients

A combination treatment of bisphosphonate and vitamin D may prevent cardiovascular disease in patients with systemic lupus erythematosus (SLE), a new study shows.

Angie Davidson

18 June 2018

Sweden

Lower Testosterone Levels May Be Linked to Greater Lupus Risk in Women, Study Finds

Angie Davidson

18 June 2018

Sweden

Lower Testosterone Levels May Be Linked to Greater Lupus Risk in Women, Study Finds

Lower testosterone levels might be the reason behind why women are at a higher risk than men of developing autoimmune diseases like lupus, new research suggests.

Angie Davidson

18 June 2018

USA

Lilly's Olumiant delivers positive Phase 2 lupus data

Angie Davidson

18 June 2018

USA

Lilly's Olumiant delivers positive Phase 2 lupus data

Eli Lilly's recently approved therapy Olumiant improved systemic lupus erythematosus (SLE) compared to placebo in a global Phase 2 study presented at the this year's Annual European Congress of Rheumatology, or EULAR, in the Netherlands.

Angie Davidson

9 June 2018

Italy

Paediatric Lupus Needs Early Treatment to Reduce Disease Activity, Prevent Organ Damage, Study Says

Angie Davidson

9 June 2018

Italy

Paediatric Lupus Needs Early Treatment to Reduce Disease Activity, Prevent Organ Damage, Study Says

Early treatment to reduce disease activity and prevent irreversible organ damage in pediatric systemic lupus erythematosus (pSLE) patients should be strongly considered, according to new study.

Angie Davidson

7 June 2018

USA

Obesity in Women Worsens Lupus, Increases Depression, Pain and Fatigue, Study Finds

Angie Davidson

7 June 2018

USA

Obesity in Women Worsens Lupus, Increases Depression, Pain and Fatigue, Study Finds

Obesity in women with systemic lupus erythematosus (SLE) is linked to worse disease activity, increased depression symptoms, and higher burden of pain and fatigue, a study reports.

Angie Davidson

5 June 2018

USA

Feinstein Institute researchers find blood markers that identify lupus risk.

Angie Davidson

5 June 2018

USA

Feinstein Institute researchers find blood markers that identify lupus risk.

Feinstein Institute for Medical Research Professor Betty Diamond, MD and colleagues discovered what they believe can identify a person’s risk for lupus by looking at the presence and amount of antibodies and a protein complex in blood.

Angie Davidson

5 June 2018

Spain

Increased Arterial Stiffness Observed in Patients with Systemic Lupus Erythematosus

Angie Davidson

5 June 2018

Spain

Increased Arterial Stiffness Observed in Patients with Systemic Lupus Erythematosus

Patients with systemic lupus erythematosus (SLE) exhibit increased central arterial stiffness, as measured by the augmentation index, compared with a healthy control population.

Angie Davidson

2 June 2018

USA

New Drug Trial Aims to Help Collect Data to Treat Lupus Patients

Angie Davidson

2 June 2018

USA

New Drug Trial Aims to Help Collect Data to Treat Lupus Patients

A new clinical drug trial in Charlottesville wants to help those struggling with lupus by using a cellphone and a watch to collect data for a more successful treatment.

Angie Davidson

28 May 2018

Korea

Severance Hospital Korea finds new treatment method for lupus nephritis

Angie Davidson

28 May 2018

Korea

Researchers at Severance Hospital have successfully found a treatment method for lupus nephritis that controls the transcription factor of inflammatory T cells.

Angie Davidson

20 February 2018

Benlysta Use Found to Be Safe and Effective

Angie Davidson

20 February 2018

Benlysta Use Found to Be Safe and Effective

Long-term use of Benlysta (belimumab), an approved therapy, is both safe and effective, reducing disease activity in most systemic lupus erythematosus patients, according to a study that followed patients in the U.S. for seven years.

IDAC Media PC

11 May 2017

USA

Studies by researchers at UT Southwestern Medical Center could lead to new treatments for lupus

IDAC Media PC

11 May 2017

USA

Two studies by researchers at UT Southwestern Medical Center could lead to new treatments for lupus and other autoimmune diseases and strengthen therapies for viral, bacterial, and parasitic infections.

IDAC Media PC

11 May 2017

Canada

Influence of ethnicity on childhood-onset systemic lupus erythematosus: Results from a multi-ethnic multicenter Canadian cohort.

IDAC Media PC

11 May 2017

Canada

We enrolled 213 childhood-onset SLE patients, and ethnicity data were available for 206 patients: white (31%), Asian (30%), South Asian (15%), black (10%), Latino/Hispanic (4%), Aboriginal (4%), and Arab/Middle Eastern (3%)...

IDAC Media PC

11 May 2017

Canada

Canadian Institute of Health Research. Research: Lupus drugs carry no significant cancer risk for patients

IDAC Media PC

11 May 2017

Canada

In this large SLE sample, there was a suggestion of higher lymphoma risk with exposure to cyclophosphamide and high cumulative steroids...

IDAC Media PC

11 May 2017

France

New hope for lupus patients

IDAC Media PC

11 May 2017

France

A clinical trial with 149 patients suffering from systemic lupus, has shown the effectiveness of a synthetic peptide developed by a team of researchers led by CNRS biologist Slyviane Muller at the Institut de Biologie Moleculaire (IBMC) in Strasbourg, France.

University of Louisville School of Medicine Researchers identify gene variants that may cause kidney problems in lupus patients

IDAC Media PC

11 May 2017

USA

Variants in a particular gene are linked with an increased risk for kidney complications in patients with lupus, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN)...

IDAC Media PC

11 May 2017

Germany

Researchers unravel how DNA damage may trigger lupus erythematosus

IDAC Media PC

11 May 2017

Germany

Scientists of the University Hospital Bonn, Germany have now discovered which signaling pathway of the innate immune system promotes autoimmune symptoms following sun-induced DNA damage...

Levels of Specific Antibodies Linked to Clinical Characteristics of Lupus, Study Reports

French Lupus Vaccine Ready to Move Into Phase III

Many Lupus Patients Reject Vaccinations, German Research Shows

Poor Sleep and Depression, via Pain, Can Affect Cognition in Lupus Patients, Study Finds

Bisphosphonates, Plus Vitamin D, May Help Prevent Heart Disease in SLE Patients

Lower Testosterone Levels May Be Linked to Greater Lupus Risk in Women, Study Finds

Lilly's Olumiant delivers positive Phase 2 lupus data

Paediatric Lupus Needs Early Treatment to Reduce Disease Activity, Prevent Organ Damage, Study Says

Obesity in Women Worsens Lupus, Increases Depression, Pain and Fatigue, Study Finds

Feinstein Institute researchers find blood markers that identify lupus risk.

Increased Arterial Stiffness Observed in Patients with Systemic Lupus Erythematosus

New Drug Trial Aims to Help Collect Data to Treat Lupus Patients

Severance Hospital Korea finds new treatment method for lupus nephritis

Benlysta Use Found to Be Safe and Effective

Studies by researchers at UT Southwestern Medical Center could lead to new treatments for lupus

Influence of ethnicity on childhood-onset systemic lupus erythematosus: Results from a multi-ethnic multicenter Canadian cohort.

Canadian Institute of Health Research. Research: Lupus drugs carry no significant cancer risk for patients

New hope for lupus patients

University of Louisville School of Medicine Researchers identify gene variants that may cause kidney problems in lupus patients

Researchers unravel how DNA damage may trigger lupus erythematosus

Research news categories by country

THE CONTENT ON THIS WEBSITE SHOULD NOT BE SEEN AS SUBSTITUTE FOR MEDICAL ADVICE. IF YOU HAVE, OR THINK YOU MAY HAVE, LUPUS, ALWAYS SEEK ADVICE FROM A QUALIFIED PHYSICIAN. FIND OUT MORE IN OUR TERMS OF USE.